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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Department Efforts 
• Iowa News 
• Opioid News 
 
Department Efforts 
 
A Look at Iowa’s Substance Use Disorder Treatment Services 
 
Through funding provided by a combination of State appropriations and the Federal (SAMHSA) 
Substance Abuse Prevention and Treatment Block Grant, Iowa has a limited provider network of 
23 “IDPH-Funded” substance use disorder (SUD) treatment providers, offering subsidized 
treatment services to financially eligible residents of all 99 counties. Services available range 
from Early Intervention and Outpatient Treatment, to Residential Treatment and Halfway House 
services.  Along with this funded provider network, IDPH licenses nearly 100 additional SUD 
programs, offering a similar range of services.  Some facts about available SUD services: 
 
• Iowa has 21 residential treatment providers with a combined 669 beds.  
• In 2017, Iowa SUD treatment providers served more than 45,000 individuals. 
• Another 30,000 Iowans received Early Intervention services from the IDPH-funded 
provider network in 2017.    
 
Specific to the opioid epidemic, the majority of Iowa’s treatment programs have expanded their 
existing services or introduced new ways to treat opioid use disorders with medications.  
Through opportunities such as the Medication Assisted Treatment – Prescription Drug and 
Opioid Addiction (MAT-PDOA) grant and the State Targeted Response (STR) grant, IDPH has 
been able to assist providers in their efforts.  Some examples of progress in the state include: 
 
• As part of the STR grant, 16 of the 23 IDPH-Funded providers have established plans to 
enhance or expand their treatment services to include MAT for opioid use disorders. 
• The number of practitioners in Iowa who are eligible to prescribe Buprenorphine for MAT 
increased from 31 in 2015, to 84 so far in 2018. 
• Through use of Medication Units, providers like UCS Healthcare (Des Moines) are 
expanding availability of MAT services to areas of the state in need.  
• Organizations like SATUCI (Marshalltown) are partnering with their local Federally 
Qualified Health Center and correctional facility to improve access to MAT for people re-
entering their communities after incarceration.  
• Prairie Ridge Integrated Behavioral Healthcare (Mason City) provides both 
Buprenorphine and Naltrexone as MAT options by using telehealth to make MAT more 
accessible to rural communities. 
 
For assistance in locating treatment services in your area, visit the Your Life Iowa webpage at 
YourLifeIowa.org or call 855-581-8111.     
 
Iowa News 
 
Iowa Board of Pharmacy Changes PMP Reporting Requirements 
 
Effective May 16, 2018, dispensers will be required to report to the Iowa Prescription Monitoring 
Program (PMP) no later than the next business day following dispensing, pursuant to 657 Iowa 
Administrative Code subrule 37.3(3). The Board adopted the change at its March 14, 2018 
regular meeting. The change in reporting frequency will offer providers and pharmacists more 
timely information when using this data in their prescribing and dispensing decision-making.  
 
For more information about the change in reporting frequency, contact Jennifer Tiffany at 
jennifer.tiffany@iowa.gov.  
 
Opioid News 
 
U.S. Surgeon General Releases Public Health Advisory 
 
U.S. Surgeon General Jerome M. Adams, M.D., M.P.H., released a public health advisory to 
urge more Americans to carry the potentially lifesaving medication, Naloxone, that can reverse 
the effects of an opioid overdose. The medication is already carried by many first responders, 
such as EMTs and police officers. 
 
The Surgeon General is now recommending that more individuals, including family, friends and 
those who are personally at risk for an opioid overdose, also keep the drug on hand.  Surgeon 
General Adams went on to say, “It is time to make sure more people have access to this 
lifesaving medication, because 77 percent of opioid overdose deaths occur outside of a medical 
setting and more than half occur at home.” 
 
An estimated 2.1 million people in the U.S. struggle with an opioid use disorder.  Rates of opioid 
overdose deaths are rapidly increasing.  Between 2010 and 2016, the number of opioid 
overdose deaths in the U.S. more than doubled, from 21,000 to more than 42,000, with the 
sharpest increase occurring for deaths related to illicitly made fentanyl and fentanyl analogs 
(synthetic opioids). 
 
To read the entire press release, click on the following link: Surgeon General. 
 
SAMHSA Announces Grant Availability for FQHCs, OTPs and Buprenorphine 
Waivered Prescribers to Improve Access to Overdose Treatment 
 
SAMHSA is accepting applications for Improving Access to Overdose Treatment (Short Title: 
OD Treatment Access) grants totaling up to $4.7 million over the next five years. 
 
SAMHSA will award OD Treatment Access funds to Federally Qualified Health Centers (FQHC), 
Opioid Treatment Programs (OTP), or practitioners who have a waiver to prescribe 
Buprenorphine to expand access to FDA-approved drugs or devices for emergency treatment of 
known or suspected opioid overdose. Grant recipients will partner with other prescribers at the 
community level to develop best practices for prescribing and co-prescribing FDA-approved 
overdose reversal drugs. After developing best practices, grant recipients will train other 
prescribers in key community sectors, as well as individuals who support persons at high risk for 
overdose. 
 
SAMHSA expects to fund up to 5 grantees up to $200,000 per year for up to five years. To learn 
more about this funding opportunity, click on the following link: SAMHSA. 
